Skip to main content

2008 | Buch

Pharmaceuticals in the Environment

Sources, Fate, Effects and Risks

herausgegeben von: Klaus Kümmerer

Verlag: Springer Berlin Heidelberg

insite
SUCHEN

Über dieses Buch

When the first green wave appeared in the mid and late 1960s, it was considered a f- sible task to solve pollution problems. The visible problems were mostly limited to point sources, and a comprehensive “end of the pipe technology” (= environmental technology) was available. It was even seriously discussed in the US that what was called “zero d- charge” could be attained by 1985. It became clear in the early 1970s that zero discharge would be too expensive, and that we should also rely on the self purification ability of ecosystems. That called for the development of environmental and ecological models to assess the self purifi- tion capacity of ecosystems and to set up emission standards, considering the re- tionship between impacts and effects in the ecosystems. This idea is illustrated in Fig. 0.1. A model is used to relate an emission to its effect on the ecosystem and its components. The relationship is applied to select a good solution to environmental problems by application of environmental technology.

Inhaltsverzeichnis

Frontmatter

General Aspects

Frontmatter
Chapter 1. Pharmaceuticals in the Environment – A Brief Summary
K. Kümmerer
Chapter 2. Special Characteristics of Pharmaceuticals Related to Environmental Fate
V. L. Cunningham

Sources, Occurrence and Fate

Frontmatter
Chapter 3. Drug Production Facilities – An Overlooked Discharge Source for Pharmaceuticals to the Environment
D. G. J. Larsson
Chapter 4. Substance Flows Associated with Medical Care – Significance of Different Sources
K. Kümmerer, A. Schuster
Chapter 5. Pharmaceutical Residues in Northern European Environments: Consequences and Perspectives
R. Kallenborn, J. Fick, R. Lindberg, M. Moe, K. M. Nielsen, M. Tysklind, T. Vasskog
Chapter 6. Antibiotics in the Environment
K. Kümmerer
Chapter 7. Veterinary Antibiotics in Dust: Sources, Environmental Concentrations, and Possible Health Hazards
G. Hamscher, J. Hartung
Chapter 8. Fate of Veterinary Medicines Applied to Soils
A. B. A. Boxall
Chapter 9. Pharmaceuticals as Environmental Contaminants: Modeling Distribution and Fate
A. Di Guardo, D. Calamari, E. Benfenati, B. Halling-Sørensen, E. Zuccato, R. Fanelli
Chapter 10. Environmental Exposure Modeling: Application of PhATE™ and Great-ER to Human Pharmaceuticals in the Environment
V. L. Cunningham
Chapter 11. Exposure Assessment Methods for Veterinary and Human-Use Medicines in the Environment: PEC vs. MEC Comparisons
C.D. Metcalfe, A.C. Alder, B. Halling-Sørensen, K. Krogh, K. Fenner, M. Larsbo, J. O. Straub, T. A. Ternes, E. Topp, D. R. Lapen, A. B. A. Boxall

Effects

Frontmatter
Chapter 12. Effects of Pharmaceuticals on Aquatic Organisms
K. Fent
Chapter 13. Another Example of Effects of Pharmaceuticals on Aquatic Invertebrates: Fluoxetine and Ciprofloxacin
G. Nentwig
Chapter 14. Effects of Antibiotics and Virustatics in the Environment
K. Kümmerer
Chapter 15. Realizing the Potential Benefits of Small Animal Models for the Aquatic Hazard Assessment of Human Pharmaceuticals: A Conceptual Approach
T. H. Hutchinson
Chapter 16. On the Ecotoxicology of Pharmaceutical Mixtures
T. Backhaus, J. Sumpter, H. Blanck
Chapter 17. Chronic Mixture Toxicity of Pharmaceuticals to Daphnia – The Example of Nonsteroidal Anti-Inflammatory Drugs
M. Cleuvers
Chapter 18. The Ecotoxicological Effects of Pharmaceuticals (Antibiotics and Antiparasiticides) in the Terrestrial Environment – a Review
H. Schmitt, J. Römbke
Chapter 19. Odorants – Potent Substances at Minor Concentrations: The Ecological Role of Infochemicals
U. Klaschka

Risk Assessment

Frontmatter
Chapter 20. European Developments in the Environmental Risk Assessment of Pharmaceuticals
J. Koschorreck, S. Hickmann
Chapter 21. The State and the Future Development/Perspective of Environmental Risk Assessment of Medicinal Products for Human Use: Aspects of Its Regulations in Japan
Y. Yoshioka
Chapter 22. Deterministic and Probabilistic Environmental Risk Assessment for Diazepam
J. O. Straub
Chapter 23. Comparison of Prospective and Retrospective Environmental Risk Assessments of Human Pharmaceuticals
T. Knacker, M. Liebig, J. F. Moltmann
Chapter 24. Methodological Aspects Concerning the Environmental Risk Assessment for Medicinal Products; Research Challenges
M. H. M. M. Montforts

Risk Management

Frontmatter
Chapter 25. Strategies for Reducing the Input of Pharmaceuticals into the Environment
Klaus Kümmerer
Chapter 26. Cost Action 636 Xenobiotics in the Urban Water Cycle – A Network for Collaboration within Europe
A. Ledin, D. Patureau
Chapter 27. Removal of Pharmaceutical Residues from Contaminated Raw Water Sources by Membrane Filtration
T. Heberer, D. Feldmann
Chapter 28. Photooxidation as Advanced Oxidation Treatment of Hospital Effluents
A. F. Martins, T. G. Vasconcelos, C. da Silveira Frank, D. M. Henriques, K. Kümmerer
Chapter 29. Pharmaceuticals and Environment: Role of Community Pharmacies
A. Niquille, O. Bugnon
Chapter 30. Mitigation of the Pharmaceutical Outlet into the Environment – Experiences from Sweden
B. Gunnarsson, Å. Wennmalm
Chapter 31. Pharmaceutical Waste
S. Castensson
Backmatter
Metadaten
Titel
Pharmaceuticals in the Environment
herausgegeben von
Klaus Kümmerer
Copyright-Jahr
2008
Verlag
Springer Berlin Heidelberg
Electronic ISBN
978-3-540-74664-5
Print ISBN
978-3-540-74663-8
DOI
https://doi.org/10.1007/978-3-540-74664-5